Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

A 39-year-old woman, G0, comes to the clinic due to a three-week history of continuous, heavy vaginal bleeding. She states that she has soaked through a thick maxi pad every 3 hours for the past week. The patient has a history of irregular menstrual cycles, with periods occurring unpredictably every 2 to 6 months since menarche. Medical history is notable for hypertension, for which she takes amlodipine. She does not use tobacco or alcohol. Her blood pressure is 138/88 mm Hg138/88 \text{ mm Hg}, pulse is 88/min88/\text{min}, and BMI is 38 kg/m238 \text{ kg/m}^2. Physical examination reveals dark, velvety patches of skin on the posterior neck and axillae. Pelvic examination shows active bleeding from the cervical os; the uterus is normal in size and non-tender. A urine pregnancy test is negative. Complete blood count shows a hemoglobin of 10.4 g/dL10.4 \text{ g/dL} and a platelet count of 250,000/mm3250,000/\text{mm}^3. Thyroid-stimulating hormone level is within normal limits. Which of the following is the most appropriate next step in management?

  1. A
    Transvaginal ultrasonography
  2. B
    Measurement of serum 17-hydroxyprogesterone
  3. Endometrial biopsyCevap
  4. D
    Initiation of oral medroxyprogesterone acetate
  5. E
    Measurement of serum free thyroxine

Cevap

Endometrial biopsy
Endometrial biopsy is the gold standard initial test for abnormal uterine bleeding in premenopausal women who possess risk factors for endometrial hyperplasia or cancer. This patient's history of oligomenorrhea since menarche, physical signs of insulin resistance (acanthosis nigricans), and obesity strongly suggest polycystic ovary syndrome (PCOS). In PCOS, chronic anovulation leads to continuous, unopposed estrogen stimulation of the endometrium without the protective shedding induced by progesterone. This significantly increases the risk of endometrial hyperplasia and carcinoma. Clinical guidelines recommend endometrial biopsy for women ≥45\ge 45 years with abnormal bleeding, AND for women <45< 45 years if they have a history of unopposed estrogen exposure, failed medical management, or persistent abnormal bleeding.

Adım Adım Çözüm

1
Identify the patient's primary presentation.
A 39-year-old premenopausal woman presenting with acute on chronic abnormal uterine bleeding.
Establishing the clinical problem directs the diagnostic algorithm.
2
Evaluate the patient's risk factors for endometrial pathology.
The patient has a history of chronic anovulation (irregular menses since menarche) and obesity (BMI 38 kg/m238 \text{ kg/m}^2), which are significant risk factors for unopposed estrogen exposure.
Unopposed estrogen increases the risk for endometrial hyperplasia and carcinoma.
3
Determine the most appropriate diagnostic test based on age and risk factors.
Guidelines recommend endometrial biopsy for women under 45 with abnormal uterine bleeding if they have risk factors for endometrial cancer.
Tissue diagnosis is required to rule out malignancy before initiating medical management.

Anahtar Kavram

Premenopausal women with abnormal uterine bleeding and risk factors for unopposed estrogen exposure (e.g., obesity, chronic anovulation) require an endometrial biopsy to rule out endometrial hyperplasia or cancer.
Bu soruyu puanla